Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases

PURPOSE: To assess the long-term effects of prolonged-release (PR) fampridine tablets (dalfampridine extended release) in clinical practice in patients with multiple sclerosis (MS) with walking impairment. PATIENTS AND METHODS: MS patients with walking impairment deemed candidates for treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Prugger, Michael, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810492/
https://www.ncbi.nlm.nih.gov/pubmed/24187513
http://dx.doi.org/10.2147/PROM.S42957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810492/
https://www.ncbi.nlm.nih.gov/pubmed/24187513
http://dx.doi.org/10.2147/PROM.S42957

Ejemplares similares